Skip to content

Mastication and sleep features study after electro-mechanical therapies and use of intraoral device in patients with Down syndrome: evaluation of muscles, sleep and saliva.

Evaluation of the function of the masticatory muscles and physiologic sleep variables after therapies of electro-mechanical bioestimulation and use of intraoral device in patients with Down syndrome: electromyography, polysomnography and salivary parameters.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3qp5np
Enrollment
Unknown
Registered
2018-02-20
Start date
2017-08-18
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome

Interventions

Randomized clinical trial including 30 Down syndrome patients with respiratory sleep disorders. Prior the study basal data will be collected, through polysomnography, surface electromyography on masse
Device
E01.370.405.255
E02.331

Sponsors

Instituto de Ciências eTecnologia ICT - Universidade Estadual Paulista Julio de Mesquita Filho - UNESP
Lead Sponsor
Instituto de Ciências eTecnologia ICT - Universidade Estadual Paulista Julio de Mesquita Filho - UNESP
Collaborator

Eligibility

Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Down Syndrome patients; both genders; snoring and mild to moderate apnea/hypoapnea index; cognitive status parcialy preserved; understand the verbal comands necessary to perform this research project; agree to participate by free will and must sign the Awareness Term. Cognitive analysis will be realized under simple comands, such as "open the mouth", "close the mouth", " bite", "relax". If patients be able to answear this simple comands, will be considered as part of the study.

Exclusion criteria

Exclusion criteria: Body mass index grater than 30; unsatisfactory dental health; not able to reach the University when is needed; have been submited to physiotherapic and orthodontic treatment at least 6 months before the begining of this study; present psychiatric disease.

Design outcomes

Primary

MeasureTime frame
Decrease of respiratory events per hour of sleep mensured through apnea/hypopnea index (AHI)evaluated through polysomnography to a minimun of AHI=10/h, after usage of the mandibular advancement oral appliance with an attached thermosensitive microchip, after usage of the hiperboloide and surface neuromuscular electrical stimulation therapy.;Improvement of electrical activity of masseter and temporallis bilateral muscles after usage of the mandibular advancement oral appliance with an attached thermosensitive microchip, after usage of the hiperboloide and surface neuromuscular electrical stimulation therapy evaluated through surface electromyography;Statistic analisys of all results in order to see if there is a better therapy, between all treatment applied in this study, that could lead in better improvement on apnea/hypopnea index and oxyhemoglobin dessaturation and on electrical activity of masseter and temporallis bilateral muscles after usage of the mandibular advancement oral appliance with an attached thermosensitive microchip, after the usage of the hiperboloide and surface neuromuscular electrical stimulation therapy.

Secondary

MeasureTime frame
Improvement on other physiologic sleep variables such as sleep architeture, arousal index and sleep eficiency given in percentage, after usage of the mandibular advancement oral appliance with an attached thermosensitive microchip, after usage of the hiperboloide and surface neuromuscular electrical stimulation therapy evaluated through Polysomnography.;Objective measurement of the mandibular advancement oral appliance usage through the evaluation of the data collected from the thermosensitive microchip attached to the oral appliance. The microchip records the days and hours that patient has used the oral appliance, through a algorithmic installed into the microchip.;Improvement of salivary parameters mensured through cortisol, "pseudomonas aeroginosas" and salivar flow - PH tests given in mililiters (ml), after usage of mandibular advancement oral appliance with an attached thermosensitive microchip, after usage of hiperboloide and after usage of neuromuscular electrical stimulation.

Countries

Brazil

Contacts

Public ContactMonica Gomes

Instituto de Ciências eTecnologia ICT - Universidade Estadual Paulista Julio de Mesquita Filho - UNESP

MFGOMES@ICT.UNESP.BR+5512 39479086

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 21, 2026